The goal of this clinical research study is to learn if therapy with bevacizumab, carboplatin, and weekly doses of paclitaxel is safe and can be tolerated in patients with newly diagnosed epithelial ovarian, primary peritoneal, or fallopian tube cancer. Researchers will also study if and how well this study therapy may help to control the disease.